New York State Common Retirement Fund Dia Medica Therapeutics Inc. Transaction History
New York State Common Retirement Fund
- $75.2 Billion
- Q2 2025
A detailed history of New York State Common Retirement Fund transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 26,300 shares of DMAC stock, worth $180,155. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,300Holding current value
$180,155% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DMAC
# of Institutions
59Shares Held
6.07MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.54MShares$10.5 Million0.0% of portfolio
-
Paragon Associates & Paragon Associates Ii Joint Venture Dallas, TX650KShares$4.45 Million4.32% of portfolio
-
Geode Capital Management, LLC Boston, MA630KShares$4.32 Million0.0% of portfolio
-
First Manhattan CO New York, NY606KShares$4.15 Million0.01% of portfolio
-
Bleichroeder LP New York, NY382KShares$2.62 Million0.47% of portfolio
About DiaMedica Therapeutics Inc.
- Ticker DMAC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,443,100
- Market Cap $181M
- Description
- DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...